Although initial clinical trials attributed less toxicity to R-bendamustine than to R-CHOP [12,14], other studies have reported more severe infection frequency with bendamustine than CHOP because it was associated with marked and prolonged reductions in T-cell counts [18]. Here, DDIT3 is linked to infection.